Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal

Lisa Vermunt*, Alegria J. L. van Paasen, Charlotte E. Teunissen, Philip Scheltens, Pieter Jelle Visser, Betty M. Tijms, Alzheimer's Disease Neuroimaging Initiative

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)E2699-E2705
Number of pages7
JournalNeurology
Volume92
Issue number23
DOIs
Publication statusPublished - 4 Jun 2019

Keywords

  • MILD COGNITIVE IMPAIRMENT
  • NEUROIMAGING INITIATIVE ADNI
  • REVERSION
  • DEMENTIA
  • PROGRESSION

Cite this

Vermunt, L., van Paasen, A. J. L., Teunissen, C. E., Scheltens, P., Visser, P. J., Tijms, B. M., & Alzheimer's Disease Neuroimaging Initiative (2019). Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal. Neurology, 92(23), E2699-E2705. https://doi.org/10.1212/WNL.0000000000007609